CoChat

Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β

Open access
Tsubakihara, Yutaro, Moustakas, Aristidis · 2018 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 169 of the 170 references it cites were found in a registry or an index.

Abstract

Metastasis of tumor cells from primary sites of malignancy to neighboring stromal tissue or distant localities entails in several instances, but not in every case, the epithelial-mesenchymal transition (EMT). EMT weakens the strong adhesion forces between differentiated epithelial cells so that carcinoma cells can achieve solitary or collective motility, which makes the EMT an intuitive mechanism for the initiation of tumor metastasis. EMT initiates after primary oncogenic events lead to secondary secretion of cytokines. The interaction between tumor-secreted cytokines and oncogenic stimuli facilitates EMT progression. A classic case of this mechanism is the cooperation between oncogenic Ras and the transforming growth factor β (TGFβ). The power of TGFβ to mediate EMT during metastasis depends on versatile signaling crosstalk and on the regulation of successive waves of expression of many other cytokines and the progressive remodeling of the extracellular matrix that facilitates motility through basement membranes. Since metastasis involves many organs in the body, whereas EMT affects carcinoma cell differentiation locally, it has frequently been debated whether EMT truly contributes to metastasis. Despite controversies, studies of circulating tumor cells, studies of acquired chemoresistance by metastatic cells, and several (but not all) metastatic animal models, support a link between EMT and metastasis, with TGFβ, often being a common denominator in this link. This article aims at discussing mechanistic cases where TGFβ signaling and EMT facilitate tumor cell dissemination.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms19113672

Cites

169 of 169 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The trajectory of differentiation change is pictorially graphed with epithelial cells on the left, hybrid E/M cells in the middle, and mesenchymal cells on the right hand of the arrow. The EMT and MET are also depicted as gradients of molecular and phenotypic change at the top of the figure and inside the main trajectory. Specific molecular and cellular attributes of epithelial and mesenchymal cells are listed on top of the relevant cell types. Important cell surface antigens are also drawn on the plasma membrane of each cell in a different color, in order to mark the molecular progression from an epithelial to a mesenchymal phenotype and the intermediate stages. At the bottom, the photomicrograph shows a mixed population of epithelial (red) and mesenchymal (dark grey) Py2T mouse breast cancer cells that have undergone EMT followed by MET. An additional cell model depicts a possible hybrid E/M cell that expresses EpCAM, CD61, and N-cadherin (N-Cad) as revealed in certain studies of circulating tumor cells. The features of EMT that are relevant to cancer are listed on the right.
Figure 1 The trajectory of differentiation change is pictorially graphed with epithelial cells on the left, hybrid E/M cells in the middle, and mesenchymal cells on the right hand of the arrow. The EMT and MET are also depicted as gradients of molecular and phenotypic change at the top of the figure and inside the main trajectory. Specific molecular and cellular attributes of epithelial and mesenchymal cells are listed on top of the relevant cell types. Important cell surface antigens are also drawn on the plasma membrane of each cell in a different color, in order to mark the molecular progression from an epithelial to a mesenchymal phenotype and the intermediate stages. At the bottom, the photomicrograph shows a mixed population of epithelial (red) and mesenchymal (dark grey) Py2T mouse breast cancer cells that have undergone EMT followed by MET. An additional cell model depicts a possible hybrid E/M cell that expresses EpCAM, CD61, and N-cadherin (N-Cad) as revealed in certain studies of circulating tumor cells. The features of EMT that are relevant to cancer are listed on the right.CC BY · PubMed Central
Figure 2 Basic TGFβ signaling diagram along with a program of TGFβ-regulated genes that contribute to the EMT. Left side, the extracellular dimeric TGFβ ligand is shown to bind to its plasma membrane receptors, the type II and type I receptors (each drawn as a dimer), causing trans-phosphorylation (circled P) of the type I receptor by the type II receptor. The type II receptor phosphorylates the polarity protein Par6, which recruits the ubiquitin ligase Smurf1 and regulates RhoA-dependent actin assembly and tight junction disassembly. The type I receptor also recruits the ubiquitin ligases TRAF4 and TRAF6, which activate the MAP-kinase pathway by ubiquitination, leading to the transcription factor phosphorylation. The type I receptor kinase also phosphorylates R-Smads, which form complexes with the Co-Smad, Smad4. In the nucleus, Smad complexes and cooperating transcription factors bound to various genes, along with co-repressors (co-activators) either repress the expression of epithelial genes or induce the expression of mesenchymal genes. Right side, a summary of the TGFβ-regulated EMT program divided into seven subprograms, each enlisting only a small representative example of genes that are involved in the EMT and cell motility. Signaling flow is indicated by black arrows (positive flow) and red T-bars (negative regulation); on the gene transcriptional start site, a red T-bar indicates negative regulation and a blue arrow indicates positive regulation of transcription.
Figure 2 Basic TGFβ signaling diagram along with a program of TGFβ-regulated genes that contribute to the EMT. Left side, the extracellular dimeric TGFβ ligand is shown to bind to its plasma membrane receptors, the type II and type I receptors (each drawn as a dimer), causing trans-phosphorylation (circled P) of the type I receptor by the type II receptor. The type II receptor phosphorylates the polarity protein Par6, which recruits the ubiquitin ligase Smurf1 and regulates RhoA-dependent actin assembly and tight junction disassembly. The type I receptor also recruits the ubiquitin ligases TRAF4 and TRAF6, which activate the MAP-kinase pathway by ubiquitination, leading to the transcription factor phosphorylation. The type I receptor kinase also phosphorylates R-Smads, which form complexes with the Co-Smad, Smad4. In the nucleus, Smad complexes and cooperating transcription factors bound to various genes, along with co-repressors (co-activators) either repress the expression of epithelial genes or induce the expression of mesenchymal genes. Right side, a summary of the TGFβ-regulated EMT program divided into seven subprograms, each enlisting only a small representative example of genes that are involved in the EMT and cell motility. Signaling flow is indicated by black arrows (positive flow) and red T-bars (negative regulation); on the gene transcriptional start site, a red T-bar indicates negative regulation and a blue arrow indicates positive regulation of transcription.CC BY · PubMed Central
Figure 3 The non-coding RNAs regulate the EMT. Epithelial (left) and mesenchymal (right) genes are listed, the latter being transcriptionally induced by TGFβ signaling (thick arrow). Thin T-bars indicate the negative regulation of EMT-TFs by miRNAs and inversely, the negative regulation of miRNA expression by the EMT-TFs or lncRNAs. Negative transcriptional regulation is shown with blue T-bars, whereas negative regulation of mRNA translation and stability by miRNAs is shown with red T-bars.
Figure 3 The non-coding RNAs regulate the EMT. Epithelial (left) and mesenchymal (right) genes are listed, the latter being transcriptionally induced by TGFβ signaling (thick arrow). Thin T-bars indicate the negative regulation of EMT-TFs by miRNAs and inversely, the negative regulation of miRNA expression by the EMT-TFs or lncRNAs. Negative transcriptional regulation is shown with blue T-bars, whereas negative regulation of mRNA translation and stability by miRNAs is shown with red T-bars.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Cited by

See all 167

Metadata

Authors
Tsubakihara, Y., & Moustakas, A.
Affiliations
Uppsala University (SE)
Corresponding author
Moustakas, Aristidis
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2018-11-20
Volume
19
Issue
11
Pages
3672
ISSN
1422-0067 (ISSN-L)
OpenAlex
W2900585188
Cited by
160
References
170
Citations by year
2026: 8 · 2025: 10 · 2024: 21 · 2023: 22 · 2022: 22 · 2021: 31 · 2020: 29 · 2019: 17
FWCI
1.89
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Ludwig Institute for Cancer Research (Uppsala Branch)
  • Cancerfonden (CAN 2015/438)
  • Vetenskapsrådet (K2013-66X-14936-10-5 to AM)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
Keywords
epithelial-mesenchymal transition, metastasis, TGF-beta, TGF-beta signaling, oncogenic Ras, cytokine signaling, signaling crosstalk, extracellular matrix remodeling, collective cell migration, circulating tumor cells, chemoresistance, tumor cell dissemination
MeSH terms
Animals, Humans, Models, Biological, Neoplasm Metastasis, Transcription Factors, Signal Transduction, Transforming Growth Factor beta, Epithelial-Mesenchymal Transition

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.